Joann G. Elmore

David Geffen School of Medicine at the University of California, Los Angeles · company speakers →

Joann G. Elmore, MD, MPH, explored the role AI can play in improving early cancer detection and discussed the PRISM trial.

Is this you? Claim this profile →

No public contact links on file.

Speaking history

AACR Special Conference: Advances in the Pathogenesis and Immune Therapies of Liver Cancer

6 December 2026 Austin, United States “Targeting Stage 0: Precision-Based Prevention”

AACR Drug Discovery and Development (AACR D3)

21 July 2026 Boston, United States “Targeting Stage 0: Precision-Based Prevention”

Sourcing speakers for your event?

Browse the speaker directory →